Darzalex Daratumumab 1800 mg Injection
Darzalex Daratumumab 1800 mg Injection is an advanced immunotherapy used in the treatment of Multiple Myeloma, a cancer that affects plasma cells in the bone marrow.
It contains daratumumab, a monoclonal antibody that specifically targets the CD38 antigen present on myeloma cells. By binding to these cancer cells, it helps the immune system recognize, attack, and destroy them, thereby slowing disease progression and improving patient outcomes.
The 1800 mg formulation is administered as a subcutaneous injection, offering faster administration time and improved patient comfort compared to traditional intravenous infusion.
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition & Content
- Active Ingredient: Daratumumab – 1800 mg
- Drug Class: CD38-directed monoclonal antibody
- Form: Subcutaneous injection (ready-to-use)
- Supporting ingredients: Stabilizers, buffering agents, and sterile delivery solution
How to Use
- Administered only by trained healthcare professionals
- Injected subcutaneously, usually in the abdominal area
- Pre-medications (antihistamines, steroids, antipyretics) may be given to reduce injection reactions
- Patients are monitored during and after administration
Dosage
Dosage depends on the treatment protocol decided by an oncologist:
- Initial phase: Weekly administration
- Intermediate phase: Every 2 weeks
- Maintenance phase: Once monthly
- Often used in combination with other anti-myeloma therapies
Uses & Treatments
Darzalex 1800 mg Injection is used for:
- Newly diagnosed multiple myeloma
- Relapsed or refractory multiple myeloma
- Combination therapy with chemotherapy or immunotherapy
- Maintenance therapy under oncology supervision
Advantages
- Faster administration compared to IV infusion
- Reduced hospital time and improved convenience
- Strong immune system activation against cancer cells
- Can be combined with standard cancer treatment regimens
- Proven improvement in survival outcomes in multiple myeloma patients
Storage Conditions
- Store in a refrigerator at 2°C to 8°C
- Do not freeze
- Keep in original packaging to protect from light
- Do not shake the vial
- Keep out of reach of children
Alternative Indian Brands / Options
Currently, Daratumumab is primarily available as the innovator brand Darzalex globally. However, in India and other regulated markets:
- Limited or emerging biosimilar daratumumab options may be available depending on approvals
- Other standard multiple myeloma therapies include:
- Bortezomib
- Lenalidomide
- Carfilzomib
All alternatives must be selected strictly under oncologist supervision.
Buy Darzalex Daratumumab 1800 mg Injection in USA – GlobMedIndia
Looking to buy Darzalex Daratumumab 1800 mg Injection in the United States? GlobMedIndia – The Medicine Exporter provides fast, safe, and secure global supply of anti-cancer medicines with reliable international logistics support.
We serve major US regions including:
- California
- Washington
- Chicago
- Los Angeles
- Houston
- Phoenix
- Austin
- Columbus
- Philadelphia
- San Antonio
- San Diego
- Dallas
- Jacksonville
Why Choose GlobMedIndia?
- Trusted international exporter of oncology medicines
- Secure cold-chain packaging for biologics
- Fast global delivery support
- Authentic and quality-checked medicines
- Dedicated assistance for prescription-based exports
Buy Darzalex 1800 mg Injection USA, Daratumumab injection supplier California, multiple myeloma treatment USA Darzalex, oncology medicine exporter India to USA, cancer drugs delivery Los Angeles New York Texas, GlobMedIndia anti cancer export, daratumumab injection online international supply, targeted therapy multiple myeloma USA treatment options
